What is the recommended dosing and duration of Augmentin (amoxicillin-clavulanate) for an elderly male with stage 2 Chronic Kidney Disease (CKD) and a Urinary Tract Infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for Elderly Male with Stage 2 CKD and UTI

For an elderly male with stage 2 CKD (GFR 60-89 mL/min) and UTI, prescribe Augmentin 375 mg (250 mg amoxicillin/125 mg clavulanate) twice daily for 7 days. 1, 2

Dosing Rationale

Stage 2 CKD represents mild renal impairment with GFR 60-89 mL/min, which requires modest dose adjustment from standard three-times-daily dosing. 2 The key principle is that twice-daily dosing prevents drug accumulation while maintaining therapeutic efficacy, as both amoxicillin and clavulanate have prolonged elimination half-lives in reduced renal function. 2, 3

Critical Dosing Considerations:

  • Avoid three-times-daily dosing in any degree of renal impairment, as this significantly increases adverse effects (crystalluria, neurotoxicity, hepatotoxicity) without proportional clinical benefit. 2

  • The pharmacokinetics of amoxicillin and clavulanate are differentially affected by renal impairment—amoxicillin clearance decreases more dramatically than clavulanate, causing the amoxicillin-to-clavulanate ratio to increase substantially as GFR declines. 3

  • For stage 2 CKD specifically, 375 mg twice daily maintains adequate urinary concentrations while accounting for the 30-40% reduction in total body clearance seen even with mild renal impairment. 3

Treatment Duration

7 days is the recommended duration for uncomplicated UTI in elderly males with CKD. 4, 5 This duration achieves microbiological cure rates of 84% at 1 week post-treatment and 67% at 1 month in patients with recurrent UTIs. 5

  • Extend to 10-14 days only if complicated features are present (pyelonephritis, systemic symptoms, structural abnormalities). 4

  • The 6-12 day range used in clinical trials showed excellent efficacy even in patients with mild chronic renal insufficiency (GFR 55-70 mL/min). 6

Monitoring Requirements

Before initiating therapy:

  • Verify renal function using creatinine clearance or eGFR to confirm stage 2 CKD and appropriate dosing. 4

During treatment:

  • Monitor for signs of drug accumulation including altered mental status, seizures (rare but serious with amoxicillin accumulation). 4
  • Assess for nephrotoxic drug interactions, particularly NSAIDs, aminoglycosides, or vancomycin that could worsen renal function. 4

Common Pitfalls to Avoid

  1. Do not use standard three-times-daily dosing (375 mg TID or 625 mg TID) in elderly patients with any degree of renal impairment—this is the most common prescribing error. 2

  2. Do not assume "stage 2" means "no adjustment needed"—even mild renal impairment (GFR 60-89) requires dose modification from standard regimens. 2, 3

  3. Elderly patients (>70 years) often have lower actual GFR than estimated, so err on the side of conservative dosing, especially if frail or multimorbid. 1

  4. The drug is well-tolerated with minimal gastrointestinal side effects at this dosing regimen (reported in only 20% of patients, all mild). 7, 5

Clinical Context for Elderly Males

Antimicrobial treatment of UTIs in older patients generally aligns with younger populations using the same antibiotics and duration, unless complicating factors exist. 1 However, diagnosis in elderly males requires careful assessment—prescribe antibiotics only if there is recent-onset dysuria OR systemic signs (fever >37.8°C, rigors, clear-cut delirium) OR costovertebral angle tenderness, regardless of urinalysis results. 1

Do not treat based solely on urinary symptoms like cloudy urine, odor changes, or nonspecific symptoms (fatigue, decreased mobility, nocturia) without the above criteria, as these have poor specificity in elderly populations. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Augmentin Dosing Considerations for Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxiclav Dosing in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate dosing and duration of Augmentin (amoxicillin-clavulanate) for a patient with End-Stage Renal Disease (ESRD) on dialysis, who has not received dialysis in four days, and has a urinary tract infection (UTI)?
What is the recommended dosing of Augmentin (amoxicillin-clavulanate) for a patient with End-Stage Renal Disease (ESRD) and a Urinary Tract Infection (UTI)?
What is the recommended dose and duration of Augmentin (amoxicillin/clavulanate) for a patient with a urinary tract infection (UTI) and potential impaired renal function?
What is the suitable dose of Augmentin (amoxicillin/clavulanate) for an elderly female patient with recurrent Urinary Tract Infections (UTIs) weighing 180 pounds?
What is the recommended dose of Augmentin (amoxicillin/clavulanate) for a renal transplant patient with impaired renal function, specifically a Glomerular Filtration Rate (GFR) of 50?
What is the role of apolipoproteins (Apo), specifically apolipoprotein A (ApoA) and apolipoprotein B (ApoB), in lipid metabolism and cardiovascular health?
How long after a cardiac catheterization (cardiac cath) procedure will I feel okay?
What is the treatment order for an adult or adolescent patient with a possible yeast infection presenting with groin smell, considering the use of nystatin powder?
How to diagnose and manage an adult patient with abnormal lambda and kappa light chain levels and severe concentric left ventricular hypertrophy?
What is the best approach to manage hypertension in a diabetic patient using Angiotensin Receptor Blockers (ARBs)?
What is the initial management for a patient presenting with a suspected bite from a regular spider, considering various patient demographics and medical histories?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.